Immunome, Inc.IMNMNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P14
Within normal range
vs 2Y Ago
-1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | -72.32% |
| 2024 | -1363.98% |
| 2023 | 73.62% |
| 2022 | -57.41% |
| 2021 | -50.21% |
| 2020 | -26.40% |
| 2019 | -29.62% |
| 2018 | 0.00% |